Department of General and Gynecological Surgery, CHU Rangueil, Toulouse, France.
Eur J Surg Oncol. 2010 Nov;36(11):1073-9. doi: 10.1016/j.ejso.2010.08.135. Epub 2010 Sep 27.
PRÉCIS: Positive endocervical margins are an important predictor of recurrence in high-grade cervical lesions, and though they do not always warrant retreatment, closer surveillance is recommended.
To identify predictors of recurrence and persistence of high-grade cervical dysplasia and to determine appropriate follow-up.
prospective pilot study.
Gynaecological surgical center.
Three hundred fifty-two patients were treated between 1999 and 2002 for high-grade lesions.
According to the accessibility of the transformation zone and the degree of dysplasia, patients were treated either by conization or by loop electrosurgical excision procedure (LEEP). Follow-up comprised colposcopy and Pap-smear screening 4-6 months after treatment as well as high-risk human papillomavirus (HR-HPV) testing before and after treatment.
underscore predictors of recurrence and propose a treatment flowchart for both management and follow-up.
Of the 352 patients, 37 (10.5%) had true recurrence 6 months after initial surgical treatment and 6 patients (1.7%) had persistent lesions. Overall, 43 patients (12.2%) were considered as having recurrent disease. Patients were followed up for 5 years with a mean of 73 months. The most important predictor of recurrence was a positive HR-HPV test at 6 months postoperatively (odds ratio 38.8, 95% confidence interval 14.09, 107.05). The second significant predictor was positive endocervical margins and the third was positive pre-treatment HPV typing. A positive post-treatment HPV test had a more significant influence on risk than a positive test before treatment.
In agreement with recent findings, our study supports the usefulness of the HR-HPV test in the follow-up of treated high-grade lesions, especially when excision margins were positive.
阳性宫颈管切缘是高级别宫颈病变复发的重要预测因素,尽管它们并不总是需要再次治疗,但建议进行更密切的监测。
确定高级别宫颈上皮内瘤变(CIN)复发和持续存在的预测因素,并确定适当的随访方案。
前瞻性试点研究。
妇科手术中心。
1999 年至 2002 年间,共有 352 例患者因高级别病变接受治疗。
根据转化区的可及性和异型程度,患者分别接受宫颈锥切术或环形电切术(LEEP)治疗。随访包括治疗后 4-6 个月行阴道镜和巴氏涂片检查,以及治疗前后行高危型人乳头瘤病毒(HR-HPV)检测。
强调复发的预测因素,并提出针对管理和随访的治疗流程图。
352 例患者中,37 例(10.5%)在初始手术治疗后 6 个月出现真性复发,6 例(1.7%)存在持续病变。总体而言,43 例(12.2%)患者被认为患有复发性疾病。患者平均随访 73 个月,随访时间为 5 年。复发的最重要预测因素是术后 6 个月 HR-HPV 检测阳性(优势比 38.8,95%置信区间 14.09,107.05)。第二个重要的预测因素是阳性的宫颈管内切缘,第三个是治疗前 HPV 阳性。治疗后 HPV 检测阳性对风险的影响大于治疗前阳性检测。
与最近的研究结果一致,本研究支持在治疗后的高级别病变随访中使用 HR-HPV 检测,尤其是在切缘阳性时。